Kinneret Livnat Savitzky

Kinneret has over 25 years of experience in senior leadership positions in the biopharmaceutical industry, including vast experience in different aspects of drug discovery and development, deal making and fund-raising.
Prior to joining Team8, Kinneret served as the CEO of FutuRx, an incubator of J&J, Takda, Bayer and OrbiMed and of BioLineRx a Nasdaq-listed drug development company focused on oncology and immunology. During her tenure, BioLineRX signed a strategic collaboration with Novartis as well as licensing agreements with Merck (MSD), Genentech and others.
Kinneret also held the position of Vice President of Biology of Compugen Ltd., cancer immunotherapy company and a leader in predictive target discovery.
Kinneret holds a B.Sc. in Biology from The Hebrew University of Jerusalem, and an M.S.c and Ph.D. with distinction in Human Genetics from Tel Aviv University.